Clinical trial Recruiting at 3 sites Interventional Ages 14 and up

Youth leadership and mindfulness program for adolescents

Official title: Can A Youth Leadership and Mindfulness Program Support Well-being in Adolescence?

Run by Boston University Charles River Campus · NCT06736522 · Data updated 2026-11-12

This study is testing a new program that teaches leadership and mindfulness skills to young people of color to see if it helps improve their mental and emotional well-being compared to a different program focused on college and career readiness.

Quick facts

Study typeInterventional
Ages14 Years and up
SexAll
Enrollment504 (estimated)
SponsorBoston University Charles River Campus
Academic / other
Locations3 sites (Chicago, Illinois and 2 other locations)
StatusRecruiting
StartedDecember 16, 2024
Main results expectedMarch 2028
Study endsMarch 2028
Registry record updatedSeptember 1, 2026
Trial IDNCT06736522 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 14 and older in grades 9-12 enrolled in partner sites in Massachusetts or Chicago.

Probably not a fit

Patients who have previously participated in the pilot phase or cannot commit to the full study will not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the feasibility and effectiveness of the Leadership, Engagement, and youth Activism Program with Mindfulness (LEAP), designed specifically for youth of color. The program consists of 14 two-hour sessions focusing on civic leadership, engagement, and mindfulness skills. Participants will be compared to a control group involved in a college and career readiness program called EnvisionIT. Assessments will be conducted at multiple time points to evaluate the program's impact on mental, emotional, and behavioral health outcomes.

Why it matters

Potential benefit: If successful, this program could enhance the mental health and civic engagement of youth of color, addressing health disparities.

How similar studies have gone: While similar programs have shown promise in enhancing youth engagement and wellbeing, this specific approach is novel in its focus on youth of color and mindfulness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adolescents ages 14 and older in grades 9-12 during the Fall/Winter or in grades 9-11 during the Spring
* Enrolled in a partner site in Massachusetts or Illinois
* Adolescents are only included with parent consent and youth assent if they are under the age of 18. Adolescents at least 18 years old can provide consent.

Exclusion Criteria:

* They participated in the pilot phase (UG3)
* They cannot commit to participation in the full study (e.g., attendance at all intervention sessions)
* They are not in grades 9-12 at a partner site
* Parent/guardian has a preferred consent language other than English or Spanish.

Where it's running

  • University of Illinois, Chicago
    Chicago, Illinois, United States
    Recruiting
  • Metco
    Boston, Massachusetts, United States
    Recruiting
  • Boston University
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Mario Cruz-Gonzalez, PhD — Massachusetts General Hospital
  • Study coordinator: Jennifer Greif Green, PhD
  • Email: jggreen@bu.edu
  • Phone: 617-353-3253

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.